Overview of Modern Commercial Kits for Laboratory Diagnosis of African Swine Fever and Swine Influenza A Viruses
Viruses · 2024
DOI: 10.3390/v16040505 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Larysa Muzykina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biomedicine Department, The Margarita Salas Centre for Biological Research (CIB) of the Spanish National Research Council (CSIC), C. Ramiro…. Hauptthemen laut MEDLINE: African Swine Fever, Orthomyxoviridae Infections, Influenza A virus, Sensitivity and Specificity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, ALLEA, CSIC and ALLEA.
Abstract (Originalsprache)
Rapid and early detection of infectious diseases in pigs is important, especially for the implementation of control measures in suspected cases of African swine fever (ASF), as an effective and safe vaccine is not yet available in most of the affected countries. Additionally, analysis for swine influenza is of significance due to its high morbidity rate (up to 100%) despite a lower mortality rate compared to ASF. The wide distribution of swine influenza A virus (SwIAV) across various countries, the emergence of constantly new recombinant strains, and the danger of human infection underscore the need for rapid and accurate diagnosis. Several diagnostic approaches and commercial methods should be applied depending on the scenario, type of sample and the objective of the studies being implemented. At the early diagnosis of an outbreak, virus genome detection using a variety of PCR assays proves to be the most sensitive and specific technique. As the disease evolves, serology gains diagnostic value, as specific antibodies appear later in the course of the disease (after 7–10 days post-infection (DPI) for ASF and between 10–21 DPI for SwIAV). The ongoing development of commercial kits with enhanced sensitivity and specificity is evident. This review aims to analyse recent advances and current commercial kits utilised for the diagnosis of ASF and SwIAV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biomedicine Department, The Margarita Salas Centre for Biological Research (CIB) of the Spanish National Research Council (CSIC), C. Ramiro de Maeztu, 9, 28040 Madrid, Spain.
- Department of Biotechnology, INIA-CSIC, Centro Nacional Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Ctra. de la Coruña Km 7.5, 28040 Madrid, Spain.
- R&D Department, Cuarte S.L., Grupo Jorge, Ctra. de Logroño km 9.2, Monzalbarba, 50120 Zaragoza, Spain.
- Interdisciplinary Laboratory of Clinical Analysis (Interlab-UMU), University of Murcia, 30100 Murcia, Spain.
ORCID-Profile: Larysa Muzykina, Lucía Barrado-Gil, Covadonga Alonso, María Montoya
Förderung
- Ministerio de Ciencia e Innovación
- ALLEA
- CSIC and ALLEA
- MCIN/AEI/10.13039/501100011033
- Spanish Ministry of Science and Innovation
- European Commission, Horizon 2020 Framework Programme European Union
Zitieren
APA
Muzykina, L., Barrado-Gil, L., Gonzalez-Bulnes, A., Crespo-Piazuelo, D., Cerón, J. J., Alonso, C., & Montoya, M. (2024). Overview of Modern Commercial Kits for Laboratory Diagnosis of African Swine Fever and Swine Influenza A Viruses. Viruses. https://doi.org/10.3390/v16040505
Vancouver
Muzykina L, Barrado-Gil L, Gonzalez-Bulnes A, Crespo-Piazuelo D, Cerón JJ, Alonso C, et al. Overview of Modern Commercial Kits for Laboratory Diagnosis of African Swine Fever and Swine Influenza A Viruses. Viruses. 2024. doi:10.3390/v16040505
BibTeX
@article{Muzykina2024,
author = {Muzykina, Larysa and Barrado-Gil, Lucía and Gonzalez-Bulnes, Antonio and Crespo-Piazuelo, Daniel and Cerón, Jose Joaquin and Alonso, Covadonga and Montoya, María},
title = {Overview of Modern Commercial Kits for Laboratory Diagnosis of African Swine Fever and Swine Influenza A Viruses},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16040505}
}
EUVIMED